EE57 Real-World Reductions in Migraine-Related Health Care Resource Utilization and Costs for Patients Initiating Fremanezumab: A 12-Month Retrospective US Claims Analysis
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.1745
https://www.valueinhealthjournal.com/article/S1098-3015(22)02051-4/fulltext
Title :
EE57 Real-World Reductions in Migraine-Related Health Care Resource Utilization and Costs for Patients Initiating Fremanezumab: A 12-Month Retrospective US Claims Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02051-4&doi=10.1016/j.jval.2022.04.1745
First page :
Section Title :
Open access? :
No
Section Order :
10270